Advertisement
Survey Series
Institutions
For Advertisers
|
|
||||
|
Gene therapy falters
Email: Brendan A Maher - bmaher@the-scientist.com News from The Scientist 2002, 3(1):20021008-04
|
||||
|
|
||||
|
Health officials and clinicians have suspended gene therapy trials for Severe Combined Immune Deficiency (SCID) in the United States, France, and Germany following observation of a leukemia-like disorder in one patient who underwent the treatment. Recently hailed as gene therapy's first real success, the therapy had restored immune function to at least 14 children with X-linked SCID, the so-called "bubble boy" disease.
|
|
|||||||||
|
|||||||||
|
